The number of Stage III CRC patients with normal transferrin was 131, and 97 of these (74.0%) received adjuvant chemotherapy; in contrast, 15 Stage III CRC patients had low transferrin, and four of them (26.6%) underwent adjuvant chemotherapy. The gene discussed is TF; the disease is colorectal carcinoma.